Respiratory therapist

Apria to Announce Fourth Quarter and Full Year 2020 Financial Results

Retrieved on: 
Thursday, March 11, 2021

INDIANAPOLIS, March 11, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the Company or Apria) (Nasdaq: APR) announced today that it will release fiscal fourth quarter and full year financial results on Tuesday, March 30, 2021 after the market closes.

Key Points: 
  • INDIANAPOLIS, March 11, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the Company or Apria) (Nasdaq: APR) announced today that it will release fiscal fourth quarter and full year financial results on Tuesday, March 30, 2021 after the market closes.
  • In conjunction, the company will host a conference call to review results at 5:00 p.m.
  • Apria is a leading provider of integrated home healthcare equipment and related services in the United States, providing home respiratory therapy, obstructive sleep apnea treatment and negative pressure wound therapy.
  • Its approximately 275 locations throughout the continental United States and Hawaii serve nearly 2 million patients each year.

Etiometry, Leading Intensive Care Clinical Decision-Support Software, Achieved Record Growth in New Relationships, Beds Served

Retrieved on: 
Tuesday, March 9, 2021

Etiometry , a leader in clinical decision-support software for the intensive care environment, today, announced significant business growth and expansion in 2020.

Key Points: 
  • Etiometry , a leader in clinical decision-support software for the intensive care environment, today, announced significant business growth and expansion in 2020.
  • Clinicians in the intensive care setting rely on patients vital signs to monitor for unexpected health events.
  • In 2020, Etiometry expanded its existing footprint with pediatric and cardiac intensive care units and extended into both neonatal and adult ICU settings.
  • As a result, the company recorded an increase of 111% in contracted intensive care units.

Tezepelumab Is the First Biologic to Consistently and Significantly Reduce Exacerbations in Broad Population of Severe Asthma Patients

Retrieved on: 
Friday, February 26, 2021

AstraZeneca is an established leader in respiratory care, and its inhaled and biologic medicines reached more than 53 million patients in 2019.

Key Points: 
  • AstraZeneca is an established leader in respiratory care, and its inhaled and biologic medicines reached more than 53 million patients in 2019.
  • Efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma: results from the phase 3 NAVIGATOR study.
  • The management of severe asthma: economic analysis of the cost of treatments for severe asthma.
  • Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma (DESTINATION) [Online].

Mabry Health Care & Rehab Center Partners with Encore Healthcare to add Respiratory Therapy Services and Pulmonary Rehab Program

Retrieved on: 
Thursday, February 25, 2021

GAINSBORO, Tenn., Feb. 25, 2021 /PRNewswire/ --Mabry Health Care & Rehab Center is excited to announce a clinical respiratory excellence partnership with Encore Healthcare, based in Livingston, TN.

Key Points: 
  • GAINSBORO, Tenn., Feb. 25, 2021 /PRNewswire/ --Mabry Health Care & Rehab Center is excited to announce a clinical respiratory excellence partnership with Encore Healthcare, based in Livingston, TN.
  • In addition to these changes, Mabry is expanding into another key service greatly needed in the Upper Cumberland area, Respiratory Therapy Services provided by Encore Healthcare.
  • Encore's Respiratory Therapy services will allow for the advanced care and management of patients with COPD and other chronic respiratory conditions including tracheostomized patients and those requiring specialty respiratory equipment.
  • Mabry Health Care & Rehab Center takes great pride in maintaining the highest standards, employing quality nurses and staff to better care for your loved one.

Encore Healthcare Names Katie Pennington, RRT as Director of Clinical Operations

Retrieved on: 
Friday, February 19, 2021

LIVINGSTON, Tenn., Feb. 19, 2021 /PRNewswire/ -- On Tuesday, February 16th, 2021, Encore Healthcare announced Katie Pennington, RRT as Director of Clinical Operationsfor the company.

Key Points: 
  • LIVINGSTON, Tenn., Feb. 19, 2021 /PRNewswire/ -- On Tuesday, February 16th, 2021, Encore Healthcare announced Katie Pennington, RRT as Director of Clinical Operationsfor the company.
  • Katie has served as Encore's Clinical Implementation Specialist over the last year and has established an outstanding reputation with Encore customers for clinical and operational excellence.
  • "Katie's dedication to the success of Encore and more importantly, to the success of the patients we serve, is inspiring to our customers and staff," said Carrie Hylton, RRT, VP of Clinical Operations for Encore.
  • "We are excited to have Katie on our team and see her grow as a Respiratory Therapist and as a leader."

Vapotherm to Participate in Fireside Chat at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Retrieved on: 
Friday, February 12, 2021

Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA.

Key Points: 
  • Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA.
  • The company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders.
  • Over 2.5 million patients have been treated with the use of Vapotherm high velocity therapy systems.
  • Vapotherm high velocity therapy is mask-free noninvasive ventilatory support and is a front-line tool for relieving respiratory distressincluding hypercapnia, hypoxemia, and dyspnea.

Ventec Life Systems Completes Historic 2020

Retrieved on: 
Friday, February 5, 2021

Ventec Life Systems completed a record-breaking year manufacturing VOCSN critical care ventilators in response to COVID-19.

Key Points: 
  • Ventec Life Systems completed a record-breaking year manufacturing VOCSN critical care ventilators in response to COVID-19.
  • New leadership will guide Ventec Life Systems through the next stage of its development to bring integrated respiratory care to patients and caregivers.
  • The past five years have seen incredible innovation and growth for Ventec Life Systems, said outgoing CEO Chris Kiple.
  • I am tremendously proud of the amazing team at Ventec Life Systems who worked tirelessly around the clock to overcome every obstacle and truly make history.

Qosina Offers Vast Selection of Critical Care Components for Respiratory Medical Device Design

Retrieved on: 
Thursday, February 4, 2021

Qosina offers countless off-the-shelf solutions for oxygen and respiratory medical device projects, stocking a range of non-sterile respiratory care components in a variety of materials, sizes, colors and configurations.

Key Points: 
  • Qosina offers countless off-the-shelf solutions for oxygen and respiratory medical device projects, stocking a range of non-sterile respiratory care components in a variety of materials, sizes, colors and configurations.
  • Qosina also stocks an assortment of respiratory accessories, such as hose clips, in-line flow indicators and more.
  • Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries.
  • Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development.

Solutions in Critical Care Awarded a Specialty Distribution Agreement With Vizient® for Select Respiratory Care Devices

Retrieved on: 
Wednesday, January 20, 2021

Solutions in Critical Care (SCC) has been awarded a distribution contract with Vizient for respiratory products.

Key Points: 
  • Solutions in Critical Care (SCC) has been awarded a distribution contract with Vizient for respiratory products.
  • Effective March 1, 2021, the new agreement gives Vizient members access to contracts for select respiratory care devices that offer increased savings.
  • Now united as Solutions in Critical Care and contracted with organizations such as Vizient, medical device manufacturers partnering with SCC now have an even stronger presence.
  • To learn more about the SCC distribution network or the products offered, contact Solutions in Critical Care at 866-367-7221 or visit www.solutionsincriticalcare.com .

Spring Gate Rehabilitation and Health Care Center Partners with Encore Healthcare to Take Over the Respiratory Therapy Department at Their Enhanced Respiratory Care (ERC) Ventilator Unit

Retrieved on: 
Wednesday, January 20, 2021

MEMPHIS, Tenn., Jan. 20, 2021 /PRNewswire/ --On Friday, January 1st, 2021, Spring Gate Rehabilitation and Encore Healthcare kicked off a partnership that will bring new management to the Respiratory Therapy Department in the Ventilator Unit.

Key Points: 
  • MEMPHIS, Tenn., Jan. 20, 2021 /PRNewswire/ --On Friday, January 1st, 2021, Spring Gate Rehabilitation and Encore Healthcare kicked off a partnership that will bring new management to the Respiratory Therapy Department in the Ventilator Unit.
  • Livingston, TN based Encore Healthcare is a leader in Post-Acute Respiratory Care programs, services, and software.
  • "We pride ourselves on providing the highest quality Respiratory Therapy services possible to our customers," said Keisha Harper, COO of Encore Healthcare.
  • "This partnership will bring a whole new culture and level of leadership to Spring Gate's Ventilator Unit and RT Department."